Maven Biotechnologies

company

About

Maven Biotechnologies develops Polaron and LFIRE, internal reflection ellipsometry analysis systems for microplates and slide disposables.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.96M
Industries
Big Data,Biotechnology,Genetics,Health Diagnostics,Medical
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

Maven Biotechnologies develops label free internal reflection ellipsometry analysis systems for microplates and slide disposables that measure molecular binding in real-time on microarrays spotted in wells or on slides. It offers Polaron, a platform for developing and performing immunoassays, rapid diagnostic screening, cell-based screening, drug-target kinetics, and protein and genomic microarrays; and LFIRE, a high density imaging system for quantitative biomarker analysis. The company serves diagnostics, pharmaceuticals, research, and industrial applications. Maven Biotechnologies, LLC was founded in 2000 and is based in Pasadena, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.96M
Maven Biotechnologies has raised a total of $1.96M in funding over 2 rounds. Their latest funding was raised on Oct 4, 2010 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 4, 2010 Grant $1.96M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Maven Biotechnologies is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant